The University of Kansas Cancer Center and Midwest Cancer Alliance have been awarded a grant to expand the reach of cancer clinical trials to Kansas’ rural communities. The six-year grant designates the team as a minority/underserved (MU) community site of...
Strekin AG (www.strekin.com), a biopharmaceutical company focused on treatments for hearing loss, announced today that it has successfully completed patient recruitment in the RESTORE study, an international, randomized, placebo-controlled, Phase 3 clinical trial of...
Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced that the Toca 5 Phase 3, randomized, multi-center clinical trial evaluating Toca 511 & Toca FC in patients with recurrent high grade glioma (HGG) undergoing...
When it comes to recruitment, LinkedIn has become one of the best tools businesses can use to attract and bring in quality talent. For patient recruitment companies, the same holds true for bringing in potential patients for clinical trials. However, when it comes to...
Concert Pharmaceuticals, Inc. (CNCE) today announced that it will present results from its recently completed Phase 2 trial of CTP-543 in patients with moderate-to-severe alopecia areata. These data will be presented in the late breaking news session at the European...
Successful trials demonstrating Rapid Acoustic Pulse (RAP) technology to reduce keloid and hypertrophic scars may be indicative of a wider range of fibrosis-related indication HOUSTON, Sept. 10, 2019 /PRNewswire/ — Soliton, Inc., (SOLY) (“Soliton” or...
Email
Text